Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies (Q32107135)
scientific article
Language:
(P31) (Q13442814)
(P304) 231-242
(P407) (Q1860)
(P433) 2
(P478) 7
(P577) Thursday, February 1, 2001
(P921) (Q323936)
(P1433) (Q332253)
(P1476) "Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies" (language: en)
(P2093) D P Ryan
J G Supko
J P Eder
M V Seiden
G Demetri
T J Lynch
A J Fischman
J Davis
J Jimeno
J W Clark
other details
description scientific article

External Links